Skip to content

Effectiveness of a Psychoeducational Group Intervention in Patients With Depression and Physical Comorbidity

Effectiveness of a Psychoeducational Group Intervention Conducted by Primary Health Care Nurses in Patients With Depression and Physical Comorbidity

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03243799
Acronym
PsiCoDep
Enrollment
504
Registered
2017-08-09
Start date
2017-11-06
Completion date
2019-12-31
Last updated
2019-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorder

Brief summary

The primary aim is to evaluate the effectiveness of an intervention based on a psychoeducational program carried out by primary care nurses, to improve the rate of remission and response of depression in patients with physical chronic illness (diabetes, COPD, asthma and / or ischemic heart disease). Secondarily, to assess the cost-effectiveness of the intervention, the effectiveness to improve the control of physical pathology, the impact on quality of life and the feasibility of the intervention. Methods: a multicentre, randomized clinical trial, with two groups and 1 year follow-up evaluation. Economic evaluation study. We will study 504 patients (252 in each group), over 50 years assigned to 25 primary care teams (PC) from Catalonia (urban, semi-urban and rural) with major depression and with at least one of the diseases: diabetes mellitus type 2, chronic obstructive pulmonary disease, asthma, and / or ischemic heart disease. They will be distributed randomly into two groups. The intervention group will participate in psychoeducational groups: 12 weekly 90-minute sessions led by two nurses from PC, consisting of health education on chronic physical illness and depressive symptoms. Main measurements: clinical remission of depression and / or response to intervention (Beck depression inventory: BDI-II). Secondary measures: improvement in control of chronic disease (blood test and physical parameters), drug compliance (test Morinsky-Green and number of packaging), quality of life (EQ-5D), medical service utilization (appointments and hospital admissions due to complications) and feasibility of the intervention (satisfaction and compliance). Evaluations will be masked and conducted at 0, 3 and 12 months. At 6 months, patients will receive a call from nurses.

Interventions

Educational group sessions for patients with depression and physical comorbidities in order to improve the degree of control of their illnesses

Sponsors

Carlos III Health Institute
CollaboratorOTHER_GOV
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Presence of at least one of the following diseases: type 2 diabetes mellitus, chronic obstructive pulmonary disease, asthma, and / or ischemic heart disease. * Meet major depression criteria at the time of the study: Score above 13 on the BDI-II scale. * Possibility of follow-up of one year by the same primary care team. * At least read and write Spanish or Catalan.

Exclusion criteria

* Diagnosis of dementia or moderate or high cognitive impairment (5 or more errors according to the pfeiffer scale). * Major depression with psychotic symptoms or with other serious psychiatric comorbidities. * Moderate or high risk of suicide (6 or more points on the MINI suicide scale). * Dependency disorders due to alcohol or other drug abuse. * Advanced stage physical disease. * Inability to travel to the center. * Be receiving some psychological therapy by the Center of mental health (CSM) of reference

Design outcomes

Primary

MeasureTime frameDescription
Changes in rate of remission of depressionAt 12 months of follow-upChanges in the score of the BDI-II scale

Secondary

MeasureTime frameDescription
Changes in the control of DM2At 12 months of follow-upChanges in HbA1c
Changes in the control of COPDAt 12 months of follow-upChanges in FEV1
Changes in the control of asthmaAt 12 months of follow-upChanges in FEV1
Changes in the control of Ischemic heart diseaseAt 12 months of follow-upChanges in LDL cholesterol
Referrals to mental healthAt 12 months of follow-upNumber of visits to mental health centers
Record of therapeutic complianceAt 12 months of follow-upMorisky-Green test
Changes in rate of remission of depressionAt 3 months of follow-upChanges in the score of the BDI-II scale
Quantification of the use of servicesAt 12 months of follow-upNumber of hospital admissions
Satisfaction with the interventionAt 3 months of follow-upSurvey at the end of the intervention
Adherence to the interventionAt 3 months of follow-upNumber of assisted sessions
Qualitative changes of the state of mind at the end of the interventionAt 3 and 12 months of follow-upbetter, equal or worse
Qualitative changes of the state of health at the end of the interventionAt 3 and 12 months of follow-upbetter, equal or worse
Changes in the quality of lifeAt 12 months of follow-upMeasured by the EuroQol scale (EQ-5D)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026